aconitine and Tonsillitis

Immune cells often express various nicotinic ACh receptor (nAChR) subtypes, including α7 nAChRs, as well as mRNA encoding secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide (SLURP)-1, an endogenous α7 nAChR allosteric ligand. We detected SLURP-1 immunoreactivity in CD205(+) dendritic cells (DCs) residing in human tonsils. Phytohemagglutinin (PHA, 10 μg/ml), a T cell activator, attenuated cell proliferation and increased the ACh content of MOLT-3 human leukemic T cells compared with the vehicle control. Methyllycaconitine (MLA, 100nM), a specific α7 nAChR antagonist, abolished all effects elicited by PHA. Recombinant (r)SLURP-1 (0.5 μg/ml) attenuated peripheral blood mononuclear cell proliferation and increased ChAT gene expression and the ACh content in MOLT-3 cells compared with the control, all of which were abolished by MLA. This suggests SLURP-1 activates cholinergic transmission by potentiating ACh synthesis and its action at α7 nAChRs, thereby facilitating functional development of T cells. These findings support the notion that SLURP-1 acts as a key modulator of immune responses.

Topics: Acetylcholine; Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antibodies; Antigens, CD; Antigens, Ly; Cell Line, Transformed; Cell Proliferation; Choline O-Acetyltransferase; Dendritic Cells; Gene Expression Regulation; Humans; Lectins, C-Type; Lymphocytes; Minor Histocompatibility Antigens; Mitogens; Nicotinic Antagonists; Palatine Tonsil; Phytohemagglutinins; Radioimmunoassay; Receptors, Cell Surface; RNA, Messenger; Tonsillitis; Urokinase-Type Plasminogen Activator